,COVID-19

Sakshi Rajoria1, Divya Nair1, Kruthi Suvarna1

  • 1Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, India.

概括

在印度的第二波疫情期间,严重的COVID-19病例显示了抗微生物路径的改变. 蛋白质组分析确定了在马哈拉施特拉州患者中改善治疗的潜在治疗点.